Status:
ACTIVE_NOT_RECRUITING
Nashville Early Diagnosis Lung Cancer Project
Lead Sponsor:
Vanderbilt-Ingram Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lung Cancer
Eligibility:
All Genders
55-80 years
Brief Summary
This screening study will address the lack of molecular strategies for the early detection of lung cancer and integrate those with epidemiological and imaging strategies. The hypothesis is that the r...
Detailed Description
It is proposed to test the hypotheses in a screening study of high risk individuals (characterized by an established prediction rule). The expected prevalence of lung cancer in this high risk group is...
Eligibility Criteria
Inclusion
- 55 - 80 years of age
- Current smoker or former smoker. If former smoker, must have quit smoking less than 15 years ago
- \>/= 30 pack year of smoking history
Exclusion
- History of diagnosis/treatment of lung cancer in the past 2 years
- History of head/neck or esophageal cancer in the last 1 year
- Inability to provide informed consent
- Participants in whom stopping anti-platelet or anti-coagulation therapy would have an adverse effect (DVT, mechanical heart valves, unstable coronary syndrome, etc.)
Key Trial Info
Start Date :
April 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2026
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT01475500
Start Date
April 1 2011
End Date
November 30 2026
Last Update
December 12 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Veterans Administration
Nashville, Tennessee, United States, 37212
2
Vanderbilt University, Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States, 37232